Revised guidelines for cardiovascular risk management - time to stop medication? A practice-based intervention study.

Area of Science:

• Cardiovascular risk management
• General practice research
• Pharmacotherapy optimization

Background:

• Dutch guideline suggests low-risk patients may not benefit from cardiovascular medication.
• Unnecessary medication treatment is prevalent in general practices.
• Target organ damage is a key factor in medication necessity.

Purpose of the Study:

• To assess the feasibility of re-evaluating patients on hypertension and/or hypercholesterolemia medication.
• To determine the consequences of medication discontinuation for low-risk patients.
• To identify factors influencing successful cessation of cardiovascular medication.

Main Methods:

• A practice-based intervention study involving six general practices.
• 833 patients treated for hypertension/hypercholesterolemia without target organ damage were included.
• Logistic regression analyzed indicators for successful medication cessation; practice differences were examined.

Main Results:

• Two-thirds of patients were re-evaluated; 61% had low cardiovascular risk.
• 42% were advised to stop medication, particularly younger, female, non-smokers.
• 9.6% of patients discontinued medication successfully for 6 months with no significant side effects.

Conclusions:

• Over 50% of patients without target organ damage may not require hypertension/hypercholesterolemia medication.
• Younger patients, females, and non-smokers are more likely candidates for medication cessation.
• Healthcare providers' (GPs, nurse practitioners) opinions influence medication stopping and restarting decisions.